Exact Mass: 235.1604
Exact Mass Matches: 235.1604
Found 94 metabolites which its exact mass value is equals to given mass value 235.1604,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Procainamide
Procainamide is only found in individuals that have used or taken this drug. It is a derivative of procaine with less CNS action. [PubChem]Procainamide is sodium channel blocker. It stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BA - Antiarrhythmics, class ia D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
N,N-Didesmethyltramadol
N,N-Didesmethyltramadol is a metabolite of tramadol. Tramadol hydrochloride (trademarked as Conzip, Ryzolt, Ultracet, Ultram in the USA; Ralivia and Zytram XL in Canada) is a centrally-acting synthetic analgesic used to treat moderate to moderately-severe pain. The drug has a wide range of applications, including treatment of rheumatoid arthritis, restless legs syndrome, and fibromyalgia. It was launched and marketed as Tramal by the German pharmaceutical company Grnenthal GmbH in 1977 (Wikipedia).
N,O-Didesmethyltramadol
N,O-Didesmethyltramadol is a metabolite of tramadol. Tramadol hydrochloride (trademarked as Conzip, Ryzolt, Ultracet, Ultram in the USA; Ralivia and Zytram XL in Canada) is a centrally-acting synthetic analgesic used to treat moderate to moderately-severe pain. The drug has a wide range of applications, including treatment of rheumatoid arthritis, restless legs syndrome, and fibromyalgia. It was launched and marketed as Tramal by the German pharmaceutical company Grnenthal GmbH in 1977 (Wikipedia).
N,N,O-Tridesmethylvenlafaxine
N,N,O-Tridesmethylvenlafaxine is a metabolite of venlafaxine (brand name: Effexor or Efexor). Venlafaxine is a bicyclic antidepressant and is usually categorized as a serotonin-norepinephrine reuptake inhibitor (SNRI), but it has been referred to as a serotonin-norepinephrine-dopamine reuptake inhibitor. It works by blocking the transporter reuptake proteins for key neurotransmitters affecting mood, thereby leaving more active neurotransmitters in the synapse. N,N,O-Tridesmethylvenlafaxine is an endogenous metabolite.
(2-trans-6-trans)-farnesoate
(2-trans-6-trans)-farnesoate, also known as (2e,6e)-farnesoic acid or trans,trans-farnesoic acid, is a member of the class of compounds known as sesquiterpenoids. Sesquiterpenoids are terpenes with three consecutive isoprene units (2-trans-6-trans)-farnesoate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (2-trans-6-trans)-farnesoate can be found in a number of food items such as chinese water chestnut, wasabi, adzuki bean, and garden onion (variety), which makes (2-trans-6-trans)-farnesoate a potential biomarker for the consumption of these food products.
5-but-2-enylidene-3-ethyl-2,3,4,7a-tetrahydro-1H-cyclopenta[b]pyridine-4,4a-diol
N-Bisdesmethyl Tramadol
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3398 CONFIDENCE standard compound; INTERNAL_ID 2015
MEX_236.1645_17.7
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 902
PROCAINAMIDE
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BA - Antiarrhythmics, class ia D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
1-[3-(diethylaminomethyl)-4-methoxyphenyl]ethanone
(+/-)-AMPAHYDROBROMIDE;ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC
Carmantadine
C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent
N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-3-methylbutan-1-amine
2-amino-2-(6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)propan-1-ol
4-((2-ETHOXYETHYL)(ETHYL)AMINO)-2-METHYLBENZALDEHYDE
4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzoic acid
(4-ethoxyphenyl)(piperidin-4-yl)methanol(SALTDATA: FREE)
Amylocaine
C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
(2-trans-6-trans)-farnesoate
(2-trans-6-trans)-farnesoate, also known as (2e,6e)-farnesoic acid or trans,trans-farnesoic acid, is a member of the class of compounds known as sesquiterpenoids. Sesquiterpenoids are terpenes with three consecutive isoprene units (2-trans-6-trans)-farnesoate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (2-trans-6-trans)-farnesoate can be found in a number of food items such as chinese water chestnut, wasabi, adzuki bean, and garden onion (variety), which makes (2-trans-6-trans)-farnesoate a potential biomarker for the consumption of these food products.
Dihydroartemisinate
A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of dihydroartemisinic acid. The major species at pH 7.3.
5-(3,4,4-Trimethylpentyl)pyridine-2-carboxylic acid
(2E,6E)-farnesoate
A polyunsaturated fatty acid anion obtained by deprotonation of the carboxy group of (2E,6E)-farnesoic acid; major species at pH 7.3.
